An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Boston Properties Announces Full-Building Lease With Leading Biotech Firm at 751 Gateway in South San Francisco
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Boston Properties (NYSE: BXP) has announced a significant lease agreement for its 751 Gateway project in South San Francisco. A leading biotech company will occupy the entire 229,000 square foot space, which is under construction and expected to be ready for occupancy in early 2024. This project marks the first phase of a larger life sciences campus at Gateway Commons, in collaboration with Alexandria Real Estate Equities. Boston Properties holds a 49% stake in the venture, which is strategically located near key transportation and amenities for the life sciences sector.
Positive
Executed a 229,000 square foot lease with a leading biotech company, indicating strong demand in the life sciences sector.
The project enhances Boston Properties' portfolio in the lucrative life sciences market with a 49% stake in the venture.
751 Gateway is part of a multi-phase campus development, suggesting potential for future growth and revenue.
Negative
The completion timeline is contingent on construction progress, introducing uncertainty regarding occupancy and revenue generation.
Potential risks involve local and national economic conditions that could impact real estate development and leasing.
BOSTON--(BUSINESS WIRE)--
Boston Properties, Inc. (NYSE: BXP), the largest publicly traded developer, owner, and manager of Class A office properties in the United States, today announced that a joint venture in which the Company has a 49% ownership has executed a 229,000 square foot lease with a leading biotech company at the venture’s 751 Gateway project in South San Francisco, California. The lease covers the entire building, which is currently under construction with initial occupancy expected in early 2024.
“South San Francisco continues to be the location of choice for leading life science companies, and 751 Gateway provides an excellent combination of location and amenities these companies use to attract talent and drive scientific discovery,” stated Bob Pester, Executive Vice President, San Francisco Region, BXP.
751 Gateway is the first phase of a multi-phase life sciences campus development project at Gateway Commons in partnership with Alexandria Real Estate Equities, Inc. The Company will own 49% of 751 Gateway upon completion. Located within walking distance to Caltrain and with direct access to Highway 101, the Gateway Commons properties will offer a mix of office and lab buildings, including best-in-class amenities within a vibrant campus atmosphere.
About BXP Life Sciences
BXP Life Sciences consists of an existing portfolio of more than three million square feet focused on the specific needs of the life sciences industry, primarily in the leading innovation markets of Boston, Cambridge, and Waltham/Lexington, Massachusetts, Montgomery County, Maryland, and San Francisco and Los Angeles, California. In addition, BXP has approximately six million square feet of life sciences-focused development opportunities, including approximately one million square feet of current lab developments and redevelopments in process that are expected to deliver in the next 36 months.
About Boston Properties
Boston Properties (NYSE: BXP) is the largest publicly traded developer, owner, and manager of Class A office properties in the United States, concentrated in six markets - Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. The Company is a fully integrated real estate company, organized as a real estate investment trust (REIT), that develops, manages, operates, acquires, and owns a diverse portfolio of primarily Class A office space. Including properties owned by unconsolidated joint ventures, the Company’s portfolio totals 52.5 million square feet and 202 properties, including nine properties under construction/redevelopment. For more information about Boston Properties, please visit our website at www.bxp.com or follow us on LinkedIn or Instagram.
This press release contains forward-looking statements within the meaning of the Federal securities laws. You can identify these statements by our use of the words “plans,” “will,” “expects,” “could,” “intends,” and similar expressions that do not relate to historical matters. You should exercise caution in interpreting and relying on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Boston Properties’ control and could materially affect actual results, performance or achievements. These factors include, without limitation, the Company’s ability to complete the development project on time, within budget or at all, the uncertainties of real estate development activity, the ability to effectively integrate development projects, the effects of local, national and international economic and market conditions, and other risks and uncertainties detailed from time to time in Boston Properties’ filings with the SEC. Boston Properties does not undertake a duty to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.